Intrexon | XON - Ordinary Share Capital

Stock Price
4.13
Daily Change
0.17 4.29%
Monthly
33.23%
Yearly
175.33%
Q2 Forecast
4.04

Intrexon reported $0 in Ordinary Share Capital for its fiscal quarter ending in June of 2024.





Ordinary Share Capital Change Date
Agenus USD 35.32M 2.51M Dec/2025
Alaunos Therapeutics USD 2.21M 131K Sep/2025
Amgen USD 539M 1000K Dec/2025
Anika Therapeutics USD 13.89M 532K Dec/2025
Arrowhead Research USD 135.7M 2.44M Sep/2025
AstraZeneca USD 1.55B 206K Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Gilead Sciences USD 1.24B 1000K Dec/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
Heron Therapeutics USD 188.31M 4.99M Dec/2025
Incyte USD 198.46M 2.33M Dec/2025
Intrexon USD 0 0 Jun/2024
Karyopharm Therapeutics USD 18.31M 18.3M Dec/2025
Ligand Pharmaceuticals USD 19.66M 19.64M Sep/2025
MacroGenics USD 63.32M 60K Dec/2025
MannKind USD 307.83M 806K Dec/2025
Merck USD 2.49B 15.79M Sep/2025
Novartis USD 1.91B 10.64M Dec/2025
Rigel Pharmaceuticals USD 17K 158K Jun/2024
Roche Holding CHF 795.62M 699.54K Dec/2025
Thermo Fisher Scientific USD 371.62M 4.09M Mar/2026
Veracyte USD 79.05M 377K Dec/2025
Xencor USD 71.87M 529K Dec/2025